4 completed, 1 terminated. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow PolyGlycoplex: new trials by email Literature Review of PolyGlycoplex trials Research Report on PolyGlycoplex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics PolyGlycopleX® - PGX®, Rice Flour (placebo) - Type II Diabetes Mellitus, Obesity | Phase 3 | Terminated | InovoBiologic Inc. | 100 | 2012-10-01 | 2021-02-11 |
| Effects of a Dietary Fibre Supplementation of a Low Calorie Diet on Appetite and Body Weight PolyGlycopleX (PGX), Rice flour - Appetite Suppression, Weight Loss | Phase 3 | Completed | Canadian Center for Functional Medicine | 20 | 2010-08-01 | 2015-10-02 |
| Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX) PolyGlycopleX (PGX) - Appetite and Hunger, Suppression, Blood Glucose, Postprandial | Phase 3 | Completed | Canadian Center for Functional Medicine | 35 | 2010-06-01 | 2015-10-02 |
| Reduction of the Glycemic Index by a Novel Viscous Polysaccharide PolyGlycopleX (PGX) - Blood Glucose, Postprandial | Phase 2 / Phase 3 | Completed | Glycemic Index Laboratories, Inc | 10 | 2006-05-01 | 2009-07-09 |
| Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia PolyGlycopleX (PGX), PolyGlycopleX (PG), PolyGlycopleX - Blood Glucose, Postprandial | Phase 2 / Phase 3 | Completed | Glycemic Index Laboratories, Inc | 20 | 2006-04-01 | 2008-12-04 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Weight Loss (1)
Canadian Center for Functional Medicine (2) · Glycemic Index Laboratories, Inc (2) · InovoBiologic Inc. (1)
Canada (5)
Alexandra L Jenkins, PhD, RD (2) · Thomas MS Wolever, MD (2) · Michael Lyon, MD (1) · Michael R Lyon, M.D. (1) · Sean Wharton, MD, FRCPC, PharmD (1)